Since my last Cardlytics update, there have been a significant number of changes with the company, leading to CDLX approaching an inflection point with significant cash flow in the near future.

In this post, I will go discuss the following CDLX updates:

1. Chase Acquiring Figg (with updated expected value calculations with dilution)

2. New CEO (Karim Temsamani)

3. New Banks / Neobanks (including AmEx)

4. BofA Renewal

5. The Marquee Dosh Partner

6. Bridg

7. Results (CF and cost savings, activation rates, 10-15% guide)

For all my notes on CDLX, including where I address additional pieces of the short thesis not discussed here, check out my Qualitative and Quantitative “Research Notes”:

• $CDLX Qualitative Research Notes: https://swany407.substack.com/p/cdlx-qual-research-notes

• $CDLX Quantitative Research Notes: https://swany407.substack.com/p/cdlx-quant-research-notes

• For more general information on Research Notes: https://swany407.substack.com/p/cdlx-research-notes

For more information related to this video:

• $CDLX Write-up: https://swany407.substack.com/p/q2-2022

• Market Cap as of 8.11.2022: ~$16/Share x 32.9M Shares ~ $525M Market Cap.

Investment Material:

• Website: http://swany407.com

• Twitter: https://twitter.com/Swany407/

• Write-ups: https://swany407.substack.com/

• Research Notes: https://www.swany407.com/research-notes

• Investing Checklist: https://www.swany407.com/investingchecklist

• Courses: https://www.swany407.com/courses

• Screener : https://www.swany407.com/finviz

Disclaimer: This content is intended for informational purposes only. This content is not investment advice. Before making any investment, you should do your own analysis. Please see the Disclaimer page for more details: https://www.swany407.com/disclaimer.

Austin Swanson (Swany407)